Products
Mel-Mont Medical develops molecular diagnostics products and technologies.
mel-montmedical.comCrawled Oct 16, 2026
Mel-Mont Medical develops molecular diagnostics products and technologies.
KLOKKARSTUA, Norway, Aug. 4, 2021 /PRNewswire/ -- Mel-Mont Medical, a boutique medical device and technology company dedicated to improving women's health
Mel-Mont Medical provides medical device news, industry updates, and company announcements.
Mel-Mont Medical is a medical device company for molecular screening.
Mel-Mont Medical develops molecular diagnostics and technology for early detection and prevention.
The Privacy Policy describes policies and procedures for collecting, using, and disclosing information when users use the Service.
MEL-MONT MEDICAL secures a **CPT proprietary laboratory assay code** from the **American Medical Association** for its **Proofer 7 mRNA test**, enabling effective clinical triage following HPV screening. The code facilitates broader adoption and reimbursement for the diagnostic tool in healthcare settings.
Mel-Mont Medical validates its **Mía by XytoTest®** self-sampling technology for molecular screening of **HPV-DNA and 7-type mRNA (E6/E7)**. The company, based in Norway, develops medical devices to advance women’s health diagnostics. This validation expands the technology’s potential for decentralized cervical cancer screening.
Mel Mont Medical compares self-collected and clinician-collected cervical samples for detecting HPV infections using 14-type DNA and 7-type mRNA tests. The study evaluates accuracy and feasibility of self-sampling methods in HPV screening. Results highlight differences in detection rates between sample types and test methodologies. Findings may inform future screening protocols for cervical cancer prevention.
Mel-Mont Medical, LLC introduces **Mía by XytoTest®**, a new product under development. The company leverages its XytoTest platform to advance this initiative, though specific details about the product’s function or target application remain unstated.